These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22165786)

  • 1. Neutropenia.
    Foster CW
    Medsurg Nurs; 2011; 20(5):262, 264. PubMed ID: 22165786
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic use of granulocyte colony-stimulating factor after chemotherapy does not affect survival rate in acute myeloid leukemia: a meta-analysis.
    Wang J; An L; Chen S; Ouyang J; Zhou R; Chen B; Yang Y
    Acta Haematol; 2009; 121(4):223-6. PubMed ID: 19546524
    [No Abstract]   [Full Text] [Related]  

  • 4. The therapeutic use of hematopoietic growth factors.
    Costa JJ
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
    [No Abstract]   [Full Text] [Related]  

  • 5. Hematopoietic growth factors for chemotherapy-induced neutropenia.
    Yalçin S
    Cancer Invest; 1999; 17(7):555-6. PubMed ID: 10518202
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of granulocyte growth factors in solid tumours.
    Diaz-Rubio E; Adrover E
    Eur J Cancer; 1994; 30A(1):120-2. PubMed ID: 7511398
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal use of granulocyte-colony-stimulating factor in patients with cancer who are at risk for chemotherapy-induced neutropenia.
    Cappozzo C
    Oncol Nurs Forum; 2004 May; 31(3):569-76. PubMed ID: 15146222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.
    Morstyn G; Sheridan W; Lieschke G; Cebon J; Layton J; Fox R
    Prog Clin Biol Res; 1990; 354B():29-36. PubMed ID: 1700441
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical applications of granulocyte colony stimulating factor (G-CSF).
    Gabrilove JL
    Growth Factors; 1992; 6(3):187-91. PubMed ID: 1382483
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors.
    Danova M; Barni S; Del Mastro L; Danesi R; Pappagallo GL
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1303-13. PubMed ID: 21916584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using filgrastim efficiently.
    Dranitsaris G
    Pharmacoeconomics; 1996 May; 9(5):466-8. PubMed ID: 10161379
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth factor frenzy.
    Quesenberry PJ
    Exp Hematol; 1993 Jul; 21(7):835-6. PubMed ID: 7686499
    [No Abstract]   [Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myelosuppression due to antineoplastic agents].
    Shigeoka Y; Shimizu E
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():287-93. PubMed ID: 18074550
    [No Abstract]   [Full Text] [Related]  

  • 16. Protocols for managing chemotherapy-induced neutropenia in clinical oncology practices.
    White N; Maxwell C; Michelson J; Bedell C
    Cancer Nurs; 2005; 28(1):62-9. PubMed ID: 15681984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of G-CSF in chemotherapy of urogenital cancers].
    Droz JP; Théodore C
    Pathol Biol (Paris); 1993 Jan; 41(1):48-9. PubMed ID: 7686286
    [No Abstract]   [Full Text] [Related]  

  • 18. [Place of CSF in pediatric oncology].
    Hartmann O; Valteau-Couanet D
    Pathol Biol (Paris); 1993 Jan; 41(1):52. PubMed ID: 7686289
    [No Abstract]   [Full Text] [Related]  

  • 19. Outline of clinical studies on recombinant human granulocyte colony stimulating factor (KRN 8601) in Japan.
    Kaneko T; Takaku F; Ogawa M
    Tokai J Exp Clin Med; 1991 Mar; 16(1):51-61. PubMed ID: 1723550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future strategy for cancer treatment using recombinant human granulocyte colony stimulating factor.
    Diehl V
    Eur J Cancer; 1994; 30A Suppl 3():S44-7. PubMed ID: 7535072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.